Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anemia, Refractory, with Excess of Blasts × Topotecan × 1 year × Clear all

Sponsor

Conditions

Small Cell Lung Carcinoma 13 Ovarian Neoplasms 12 Neuroblastoma 10 Fallopian Tube Neoplasms 8 Neoplasms 5 Uterine Cervical Neoplasms 4 Ganglioneuroblastoma 4 Carcinoma, Ovarian Epithelial 4 Brain Neoplasms 4 Retinoblastoma 3 Sarcoma, Ewing 2 Recurrence 2 Medulloblastoma 2 Leukemia, Myeloid, Acute 2 Glioma 2 Carcinoma, Non-Small-Cell Lung 2 Wilms Tumor 1 Thrombocythemia, Essential 1 SCLC, Extensive Stage 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinal Neoplasms 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pleuropulmonary blastoma 1 Pediatric Brain Tumor 1 Osteosarcoma 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1 Meningioma 1

Interventions

Cyclophosphamide 15 fludarabine phosphate 12 Whole-Body Irradiation 12 Mycophenolic Acid 12 fludarabine 11 Tacrolimus 8 Peripheral Blood Stem Cell Transplantation 8 Busulfan 8 Melphalan 7 Granulocyte Colony-Stimulating Factor 5 Cyclosporine 5 Azacitidine 5 Filgrastim 4 venetoclax 3 Cord Blood Stem Cell Transplantation 3 Biopsy 3 thymoglobulin 2 decitabine and cedazuridine drug combination 2 Vorinostat 2 Thiotepa 2 Specimen Handling 2 Sirolimus 2 Rituximab 2 Methotrexate 2 Hematopoietic Stem Cell Transplantation 2 Etoposide 2 Cyclosporins 2 Clofarabine 2 Bone Marrow Transplantation 2 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡